Is Jeevan Scientific Technology a good stock to invest in?

Jeevan Scientific Technology can be analyzed on the following key metrics - TTM P/E: 525.49 Sector P/E: 0 Dividend Yield: 0% D/E ratio: -

Jeevan Scientific Technology Share Price

Sector: Biotechnology & Drugs

Powered by

39.39 +0.90 (2.34%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 38.00

Today’s High 39.40

52 Week Low 36.50

52 Week High 67.80

Key Metrics

Market Cap (In Cr) 62.36
Beta 1.22
Div. Yield (%) 0
P/B 1.25
TTM P/E 525.49
Sector P/E 0
D/E 0
Open Price 38
Prev Close 38.49

View All Metrics

Jeevan Scientific Technology Analysis

Price Analysis

1 Week

2.15%
3 Months

-1.77%
6 Month

-20.94%
YTD

-20.58%
1 Year

-24.61%

Risk Meter

50% Low risk
50% Moderate risk
50% Balanced Risk
50% High risk
50% Extreme risk

Jeevan Scientific Technology Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
46.84

Selling/ General/ Admin Expenses Total
17.06

Depreciation/ Amortization
6.25

Other Operating Expenses Total
18.57

Total Operating Expense
45.68

Operating Income
1.16

Net Income Before Taxes
0.05

Net Income
0.13

Diluted Normalized EPS
0.04

Period
2024

Total Revenue
39.65

Selling/ General/ Admin Expenses Total
16.98

Depreciation/ Amortization
5.93

Other Operating Expenses Total
14.23

Total Operating Expense
40.96

Operating Income
-1.31

Net Income Before Taxes
-1.6

Net Income
-1.3

Diluted Normalized EPS
-0.84

Period
2023

Total Revenue
36.18

Selling/ General/ Admin Expenses Total
16.38

Depreciation/ Amortization
5.07

Other Operating Expenses Total
15.51

Total Operating Expense
39.96

Operating Income
-3.78

Net Income Before Taxes
-3.68

Net Income
-3.06

Diluted Normalized EPS
-1.98

Period
2022

Total Revenue
56.55

Selling/ General/ Admin Expenses Total
15.02

Depreciation/ Amortization
3.68

Other Operating Expenses Total
17.06

Total Operating Expense
43.16

Operating Income
13.4

Net Income Before Taxes
18.35

Net Income
12.26

Diluted Normalized EPS
8.15

Period
2021

Total Revenue
47.48

Selling/ General/ Admin Expenses Total
12.53

Depreciation/ Amortization
3.97

Other Operating Expenses Total
16.4

Total Operating Expense
33.54

Operating Income
13.94

Net Income Before Taxes
13.65

Net Income
11.74

Diluted Normalized EPS
7.67

Period
2020

Total Revenue
24.9

Selling/ General/ Admin Expenses Total
10.45

Depreciation/ Amortization
3.92

Other Operating Expenses Total
19

Total Operating Expense
34.23

Operating Income
-9.33

Net Income Before Taxes
-10.54

Net Income
-8.59

Diluted Normalized EPS
-5.61

Period
2019

Total Revenue
26.13

Selling/ General/ Admin Expenses Total
8.36

Depreciation/ Amortization
3.13

Other Operating Expenses Total
10.7

Total Operating Expense
23.83

Operating Income
2.29

Net Income Before Taxes
1.37

Net Income
1.11

Diluted Normalized EPS
0.74

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Jeevan Scientific Technology Technical

Moving Average SMA

5 Day38.78
10 Day38.51
20 Day39.13

50 Day40.61
100 Day42.02
300 Day47.3

Jeevan Scientific Technology Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Vasundhara Rasayans
209.3
4.05
1.97
398
185.05
66.6

Vista Pharmaceuticals
10.34
-0.35
-3.27
16.59
9.1
63.35

Jeevan Scientific Technology
39.39
0.9
2.34
67.8
36.5
62.36

Lasa Supergenerics
10.29
0.49
5
33.49
8.52
51.55

Deccan Health Care
20.3
0.83
4.26
39.1
16
47.48

Jeevan Scientific Technology Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

30-May-25
Audited Results

06-Feb-25
Quarterly Results

08-Nov-24
Quarterly Results

09-Aug-24
Quarterly Results

30-May-24
Audited Results

14-Feb-24
Quarterly Results

13-Nov-23
Quarterly Results

14-Aug-23
Quarterly Results

27-May-23
Audited Results

08-Feb-23
Quarterly Results

Meeting Date
Announced on
Purpose

27-Mar-25
03-Mar-25
EGM

09-Aug-24
18-Jul-24
AGM

29-Sept-23
18-Sept-23
AGM

24-Apr-23
31-Mar-23
EGM

25-Apr-22
25-Mar-22
EGM

15-Sept-21
09-Aug-21
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

30-May-22
-
21-Sept-22
1.2

09-Aug-21
08-Sept-21
07-Sept-21
0.5

View All

Company Profile

ABOUT Jeevan Scientific Technology

Industry Biotechnology & Drugs
ISIN INE237B01018
BSE Code 538837

Jeevan Scientific Technology Limited provides technology-driven services and solutions to its clients across the globe. The Company’s service portfolio enables its clients to provide an integrated solution for the management of clinical data from its inception to completion. It offers a range of clinical trial services from Phase II to IV for pharmaceutical, biotechnology and medical devices to bring new drugs and devices. It also provides its services to other areas, such as cosmetics and nutraceuticals. Its clinical trial services include medical writing, clinical trial management, clinical trial monitoring, drug safety management, clinical data management, biostatistics and statistical programming, and quality assurance. It offers comprehensive pharmacovigilance and safety monitoring services from early development support through post-approval initiatives. BA/BE Studies offers clinical services, bioanalytical services, pharmacokinetic & bio-statistics, and glucose clamping.

MANAGEMENT

Srinivas Maram Chief Executive Officer
Krishna Kuchipudi Vice Chairman of the Board, Managing Director
Venkateswara Rao Ravipati Chief Financial Officer
Krishna Kodati Chief Compliance Officer, Company Secretary
Snigdha Mothukuri Executive Director
Y. Rao Executive Director

JEEVAN SCIENTIFIC TECHNOLOGY SUMMARY

Jeevan Scientific Technology is trading 2.34% upper at Rs 39.39 as compared to its last closing price. Jeevan Scientific Technology has been trading in the price range of 39.40 & 38.00. Jeevan Scientific Technology has given -20.58% in this year & 2.15% in the last 5 days.

Jeevan Scientific Technology has TTM P/E ratio 525.49.

The company posted a net profit of -1.3 Crores in its last quarter.

Listed peers of Jeevan Scientific Technology include Vasundhara Rasayans (1.97%), Vista Pharmaceuticals (-3.27%), Jeevan Scientific Technology (2.34%) etc.

Jeevan Scientific Technology has a 38.05% promoter holding & 61.95% public holding.

FAQs about Jeevan Scientific Technology

Jeevan Scientific Technology is trading at 39.39 as on 27 Jun, 2025 3:28:59 PM. This is 2.34% upper as compared to its previous closing price of 38.49

The market capitalization of Jeevan Scientific Technology is 62.36 Cr as on 27 Jun, 2025 3:28:59 PM.

The 52 wk high for Jeevan Scientific Technology is 67.80 whereas the 52 wk low is 36.50

Jeevan Scientific Technology can be analyzed on the following key metrics -

TTM P/E: 525.49
Sector P/E: 0
Dividend Yield: 0%
D/E ratio: -

Jeevan Scientific Technology reported a net profit of 0.13 Cr in 2025.

Jeevan Scientific Technology Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Jeevan Scientific Technology Share Price

Price Range

Key Metrics

Jeevan Scientific Technology Analysis

Jeevan Scientific Technology Financials

Forecast

Forecast

Forecast

Jeevan Scientific Technology Technical

Jeevan Scientific Technology Peers

Jeevan Scientific Technology Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Jeevan Scientific Technology

MANAGEMENT

JEEVAN SCIENTIFIC TECHNOLOGY SUMMARY

FAQs about Jeevan Scientific Technology

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue